Good morning. Wall Street rallied yesterday, then faded. Sentiment is poor, and surprisingly solid results from Facebook (still boycotting “Meta” around here) after the bell seem unlikely to change that. But readers have suggested plenty of good reasons to be cheerful: it’s spring, Trump is out of the White House, and Russia is losing. Keep
Your browser does not support playing this file but you can still download the MP3 file to play locally. Russia raised the spectre of nuclear war this week as it struggles to make headway in Ukraine. How seriously should this threat be taken and can Vladimir Putin rely on his friendship with China’s Xi Jinping?
One thing to start: The UK Serious Fraud Office deployed investigators to sites connected with Sanjeev Gupta’s GFG Alliance on Wednesday to demand documents as it steps up its probe into the industrialist’s empire. A Tiger cub risks losing his stripes In May 2020, a scathing report from short seller Muddy Waters alleged Chinese online
The writer is the founder and managing director of capital markets think-tank New Financial In the latest round of self-flagellation over the state of the UK stock market and the City of London, it is worth remembering the words of American writer HL Mencken that “for every complex problem there is an answer that is
It might seem like business-as-usual in the post-pandemic western art world, but some of the alternative models initiated during the lockdowns are finding their footing. One is the Fair Art Fair (FAF), an app launched last September by the London artist-gallerist Stacie McCormick, with some Arts Council backing. Despite its name, the platform operates more
Bill Hwang, founder of collapsed family office Archegos Capital Management, has been arrested by US authorities and charged with racketeering, fraud and market manipulation. The indictment unsealed on Wednesday accused Hwang, 58, and former chief financial officer Patrick Halligan, 45, of using Archegos as an “instrument of market manipulation and fraud” with “far-reaching consequences for
McKinsey’s managing partner has pushed back against allegations that the consultancy breached conflict of interest rules by advising opioids producers on how to “turbocharge” sales while also working for US health regulators seeking to tackle a deadly painkiller overdose epidemic. Bob Sternfels told a US congressional committee on Wednesday that he regretted McKinsey did not